showed a trendp = 0.066
Similarly, alterations in CDKN2A (including pathogenic/VUS mutations or CNV loss) showed a trend towards a higher frequency in the SCC group (6/8 cases, 75.0%) than in the CC group (2/8 cases, 25.0%) ( p = 0.066).
Similarly, alterations in CDKN2A (including pathogenic/VUS mutations or CNV loss) showed a trend towards a higher frequency in the SCC group (6/8 cases, 75.0%) than in the CC group (2/8 cases, 25.0%) ( p = 0.066).